ExportData ^Company

ImmunoMind uses AI and multi-omics to predict preclinical and clinical efficacy of cell therapies (CAR-T, TCR-T, Treg, gdT) early, helping drug developers focus on therapies that work. Moonshot startup from UC Berkeley SkyDeck We improve the design of T-cell therapies today to make them more efficient and safer for patients tomorrow